OTCPicks.com

FEATURED COMPANY

XSUNX INCORPORATED (OTCBB: XSNX)

Detailed Quote: http://www.otcpicks.com/quotes/XSNX.php

Company Profile: http://www.otcpicks.com/xsunx/xsunx.htm

Xsunx, Inc., a thin-film photovoltaic (TFPV) company, focuses on developing thin film photovoltaic (TFPV) amorphous silicon solar cell manufacturing processes to produce TFPV solar modules. Its product includes XsunX ASI-120 module, which is a 125 peak watt TFPV solar module utilizing glass substrates and a proprietary semiconductor manufacturing system. XsunX ASI-120 provides for a module delivering high power output, and size and framing that would allow for the use of various existing mounting systems. The target markets for the TFPV solar module include solar farms, government agencies, and utility companies, as well as power purchase agreements and large commercial installations worldwide. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is headquartered in Aliso Viejo, California.

XSNX News:

May 19 - XsunX Announces Agreement with Praxair, Securing Key Manufacturing Facility Gas Needs

XsunX, Inc. (OTCBB: XSNX), a solar technology company, announced that it has signed an agreement with Praxair, Inc. (NYSE: PX) for the supply of bulk industrial gases for its new multi-megawatt thin film photovoltaic (TFPV) solar manufacturing facility near Portland, Oregon. XsunX is refurbishing an existing 90,000 sq. ft. building, located in Wood Village, to house its integrated TFPV manufacturing operations.

Praxair is a leading producer of industrial gases in North America and is uniquely positioned to meet the requirements for reliable supply of all gases required. "XsunX joins a growing number of customers that value Praxair's capabilities to reliably supply high-purity gases, sputtering targets and services for the PV industry. We look forward to supporting XsunX's production of PV modules and to help drive efficiencies in their operations," said Ray Roberge, president, Praxair Electronics.

"The agreement will provide for Praxair's expertise in the design, installation, and management of our gas handling and delivery systems and a long term contract to supply the bulk of our manufacturing gas needs," stated Mr. Tom Djokovich, CEO for XsunX. "We are pleased that such a major part of the integrated thin film TFPV manufacturing process is in good hands. Having secured gas supplies with Praxair to support a large part of our thin film TFPV manufacturing processes, we have begun to meet our short and mid term goals in the build out and supply of our multi-megawatt thin film photovoltaic solar manufacturing facility," concluded Djokovich.

ABOUT PRAXAIR INC.

Praxair is the largest industrial gases company in North and South America, and one of the largest worldwide, with 2007 sales of $9.4 billion. The company produces, sells and distributes atmospheric and process gases, and high-performance surface coatings. Praxair products, services and technologies bring productivity and environmental benefits to a wide variety of industries, including aerospace, chemicals, food and beverage, electronics, energy, healthcare, manufacturing, metals and others. More information on Praxair is available on the Internet at www.praxair.com.

FEATURED COMPANY

BIOSOLAR INCORPORATED (OTC: BSRC)

Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php

Company Profile: http://www.otcpicks.com/biosolar/biosolar-2.htm

BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.

BSRC News:

May 19 - BioSolar's Dr. Stan Levy Selected to Present Company's Breakthrough BioBacksheet™ Solar Cell Technology at Key Industry Meeting

Chief Technology Officer to Speak at SPIE, the Largest Optical Science and Technology Meeting in North America

BioSolar(TM), Inc. (OTCBB: BSRC), developer of a breakthrough technology to produce bio-based materials from renewable plant sources that reduce the cost of photovoltaic solar cells, announced that Dr. Stan Levy, the company's Chief Technology Officer, will present at the SPIE Symposium on Solar Applications and Energy conference on Tuesday, August 12, 2008 in San Diego, CA.

Dr. Levy will present findings from the company's technology development program, which led to BioSolar's breakthrough photovoltaic cell component, the BioBacksheet(TM). He will speak to thousands of engineers and researchers gathered for the SPIE symposium, the largest optical science and technology meeting in North America.

"Dr. Levy has spearheaded our technology development efforts, and in a highly efficient fashion, delivered a uniquely sophisticated product that has stimulated interest on the part of a significant number of major solar cell manufacturers," said Dr. David Lee, CEO of BioSolar. "The submissions panel at the SPIE Symposium on Solar Applications and Energy recognizes the unique nature of our new product and has asked Dr. Levy to deliver an oral presentation, rather than the more common poster presentation. This forum will allow Dr. Levy to discuss in detail the various scientific breakthroughs underlying our BioBacksheet(TM)."

BioSolar recently announced that the company has delivered BioBacksheet(TM) samples to a select group of solar cell manufacturers in multiple regions of the country. BioSolar also has received numerous requests for analysis samples from high-volume manufacturers, located in the U.S. and abroad.

"The high level of industry interest in our new product and Dr. Levy's invitation to speak at SPIE are tributes to the significance of his contributions to BioSolar and our shareholders," said Dr. Lee.

ABOUT SPIE

SPIE is an international membership society, serving scientists and engineers in industry, academia, and government, as well as companies producing leading-edge products. SPIE constituents work in a wide variety of fields that utilize some aspect of optics and photonics, which is the science and application of light. SPIE Optics+Photonics is the largest optical sciences and technology meeting in North America, including over 55 courses and workshops. The Solar Energy + Applications track of the conference is dedicated to finding ways to move toward secure, affordable, and environmentally sustainable energy to meet the world's accelerating energy needs. For more information, visit http://spie.org/solar-energy.xml.

FEATURED COMPANY

USA SUPERIOR ENERGY (OTCBB: USSUE)

Detailed Quote: http://www.otcpicks.com/quotes/USSUE.php

Company Profile:
http://www.otcpicks.com/usa-superior-energy/usa-superior-energy-3.htm

USA Superior Energy Holdings, Inc., a development stage company, operates in the energy industry in the United States. The company, through its wholly owned subsidiary, USA Superior Energy, Inc., engages in the development, ownership, and operation of prospects and energy projects in East and Southeast Texas. It also focuses on using nitrogen technology to recharge and produce oil and gas from under-pressured partially depleted reservoirs. The company was founded in 2005 and is based in Houston, Texas.

USSUE News:

May 20 - USA Superior Reports 2007 Results

USA Superior Energy Holdings, Inc. (OTCBB: USSUE) (the "Company"), a Houston-based energy company focused on acquiring, owning, operating and applying enhanced oil recovery ("EOR") techniques to existing shallow fields of oil and gas that have been idle or marginally producing, reported its operating results for the year ended December 31, 2007. On May 16, 2008, the Company filed its Annual Report on Form 10-K for the twelve months ended December 31, 2007. It is recommended that interested parties consult the Form 10-K report for additional information on the Company's 2007 operating results and financial condition.

Mr. Rowland Carey, Chairman and CEO, stated: "2007 was a seminal year for our company. Essentially it was a start up year with minor revenues and losses associated with our reverse merger and issuances of stock to key employees as we prepared the company for additional growth. Accomplishments during the year were (1) becoming a public company to provide access to the capital markets, (2) the acquisition of our most substantial asset, the Bateman Project, and (3) the preparation of that project for EOR operations to begin in 2008.

"As we operate in 2008, we are focused on (1) strengthening our management team to bring expanded talent and discipline to manage our growth, (2) increasing our capital base to fund our growth, (3) continuing our business strategy of acquiring and joint venturing shallow fields of oil and gas that have been idle or marginally producing, (4) accelerating oil production from the Bateman Project and (5) communicating more effectively with the capital markets. We continue to believe that efficient low-cost enhanced recovery of oil and gas in existing proven fields can bring outstanding returns to our investors."

FEATURED COMPANY

KCM HOLDINGS CORPORATION (OTC: KCMH)

Detailed Quote: http://www.otcpicks.com/quotes/KCMH.php

Company Profile:
http://www.otcpicks.com/kcm-holdings/kcm-holdings-2.htm

KCM Holdings Corporation is a strategic business development and holdings company specializing in a broad range of business incubation, support, design and development ventures. For more information, visit www.thekcmgroup.com.

KCMH News:

May 19 - KCM Signs $800,000 Consulting Agreement; Washington Government Services Expert Joins KCM Team

KCM Holdings Corp. (OTC: KCMH) announced the addition of consultant Mr. Mike Dement of Multi Management Services Inc. to the KCM team. Mr. Dement is an integral part of the KCM strategy to provide strategic planning and consulting services to federal, state and local agencies. As an experienced government sourcing liaison, Mr. Dement will generate a minimum of $800,000 in KCM government contract revenue throughout the remainder of 2008.

Mr. Dement brings with him a wealth of experience that includes his work with Multi Management Services Inc. Serving as a sourcing liaison for a host of client companies, Mr. Dement has generated over $3,000,000 dollars in closed government contract revenue for Multi Management Services clients, before working with KCM.

According to the COO of KCM, Ed Kang, Mike Dement “is a proven heavy hitter when it comes to being able to close government contracts as a revenue generation strategy. Our attitude is if you want something done, bring in the experts, and that is what we have done with Mike. $800,000 in government contracts is substantive revenue for a new company to generate off a new strategy, and in only a few short months, but that’s what sets KCM apart from many other pink sheet companies. We are committed to generating substantive revenue.”

Visit www.thekcmgroup.com for KCM investor information and to watch investor videos.

FEATURED COMPANY

USA VIDEO INTERACTIVE CORPORATION (OTCBB: USVO)

Detailed Quote: http://www.otcpicks.com/quotes/USVO.php

Company Profile: http://www.otcpicks.com/usa-video/usa-video.htm

USA Video Interactive Corp. ("USVO") designs and markets technology for delivery of digital media. USVO developed its MediaEscort™, MediaSentinel™ and SmartMark™ digital watermarking products and technology to provide a robust means for producers and distributors to invisibly protect their content. USA Video Technology Corp., a wholly owned subsidiary of USVO, holds the pioneering patent for store-and-forward video, filed in 1990 and issued by the United States Patent and Trademark Office on July 14, 1992; it has been cited by at least 165 other patents. USVO holds similar patents in Germany, Canada, England, France, Spain, Italy, and Japan. Visit www.usvo.com or the company showcase on Investoideas.com at www.investorideas.com/CO/USVO/Default.asp.

USVO News:

May 20 - Gerry Kaufhold, Founder and Analyst at In-Stat's Converging Markets and Technologies Information Research Service, Talks About USA Video Interactive Corp.

Gerry Kaufhold, founder and Principal Analyst at In-Stat's Converging Markets and Technologies Information Research Service, was interviewed by www.DigitalMediaStocks.com, an investor and industry portal for the digital media sector within Investorideas.com. Digital media companies discussed in the interview include watermarking company USA Video Interactive Corp. (OTCBB: USVO) (CDNX: US.V), Philips Electronics, Data Mark Technologies, Twentieth Century Fox Home Entertainment, a subsidiary of Twentieth Century Fox Film Corporation, a News Corp. company and CBS Corp.'s planned $1.8 billion acquisition of CNET Networks Inc.

Mr. Kaufhold has successfully predicted some notable technology trends, including the growth of CD-ROM drive for personal computers, as well as market shares for worldwide unit shipments of MPEG-related semiconductor devices. Discussing trends moving forward, Mr. Kaufhold notes, "Three key areas of growth for emerging digital content include: Blue Ray Optical Discs and Blue Ray TV and Movie titles coming from the studios, Social Networks with high definition video sharing and electronic delivery of high quality digital media."

Mr. Kaufhold goes on to discuss forensic watermarking technology deployed by several companies, the differentiation of technologies and some of the public companies in the sector.

"There is a small company in Connecticut called USA Video Interactive that I have been talking to for six years. They are a great example of the rest of the industry, in that it has taken them several years to develop their technology, prove it and make it robust enough to start using it. Just recently they signed a deal with Twentieth Century Fox Home Entertainment for high speed internet delivery of electronic files. Fox needs to be able to preview movies to buyers at Target and Wal-Mart and to work around direct theft at the mailroom; they now defend against it with USA Video's MediaEscort that automatically embeds watermarks or SmartMarks into every frame of the video during internet delivery. So if the content leaks out, they know exactly which computer to go and investigate. This is a very solid and robust approach to identifying leaks and theft."

To listen to the entire Podcast/Audio Interview go to:

http://s3.amazonaws.com/static.investorideas.com/podcasts/2008/051608a.mp3.

STOCKS TO WATCH

ADOLOR CORPORATION (NASD: ADLR)
"Up 3.17% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ADLR.php

Adolor Corporation engages in the discovery, development, and commercialization of prescription pain management products primarily in the United States. The company's lead product candidates include Entereg, which is a small molecule, mu-opioid receptor antagonist designed to block the unwanted effects of opioid analgesics on the gastrointestinal tract; and Delta opioid receptor agonists that is in Phase I clinical trail for various pain indications. It also offers a product that combines alvimopan with an opioid analgesic. Adolor Corporation has collaboration agreements with GlaxoSmithKline for the development and commercialization of Entereg in multiple indications; and Pfizer for the development and commercialization of two Delta agonists for pain. In addition, it has various discovery research programs focused on the identification of novel compounds for the treatment of pain. The company was founded in 1993 and is based in Exton, Pennsylvania.

ADLR News:

May 20 - Adolor and GlaxoSmithKline Announce FDA Approval of Entereg® (alvimopan) for the Management of Postoperative Ileus (POI)

First FDA Approved Therapy for POI

Adolor Corporation (NASD: ADLR) and GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Entereg® (alvimopan) capsules to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery. Postoperative ileus (POI) is a condition that affects almost all patients undergoing this type of surgery and can cause significant discomfort in addition to prolonging hospital stays for patients. Entereg is indicated to accelerate upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. Entereg will be available for short-term use in hospitals registered under the Entereg Access Support and Education (E.A.S.E.™) program.

“The approval of Entereg in POI represents a major milestone for Adolor, and is the culmination of a substantial collaborative effort among Adolor, GlaxoSmithKline, and our clinical investigators,” said Michael R. Dougherty, president and chief executive officer of Adolor Corporation. “Entereg is the first and only product that has demonstrated the ability to address this serious condition, which has negative consequences for patients, and imposes considerable expense on the healthcare system.”

”We are proud to join Adolor in offering bowel resection patients and surgical teams the only therapy proven to consistently accelerate GI recovery in patients and time to hospital discharge order written,” said Anne Whitaker, vice president of GlaxoSmithKline's recently formed Critical and Supportive Care Business Unit. “Entereg is an important new product for GSK to offer our longstanding hospital customers.”

Entereg is a peripherally acting mu-opioid receptor (PAM-OR) antagonist. The benefits of Entereg were demonstrated in five clinical studies in which all of the more than 2,500 bowel resection patients enrolled (including those in the placebo group) were placed on an accelerated postoperative care pathway, which included nasogastric tube removal before the first postoperative dose, early ambulation and early feeding. The endpoint of these studies was time to achieve recovery of both upper and lower GI function, reported as GI2 data in the package insert, representing resolution of POI. Entereg accelerated the time to recovery of GI function and reduced the time to hospital discharge order written as compared to placebo. Entereg did not reverse opioid analgesia in these patients.

“Delayed recovery of GI function, often called postoperative ileus, is one of the principal causes of patient discomfort and extended hospital stay following bowel resection surgery,” said Dr. Anthony Senagore, vice president research, Spectrum Health and Professor of Surgery, Michigan State University in Grand Rapids. “Entereg is a welcome and much needed addition to peri-operative care because it allows us to manage POI without compromising analgesia. With this medication, we have an opportunity to help bowel resection patients recover their GI function more quickly and get them discharged earlier. Since many of these patients are undergoing resections for colorectal cancer or other serious conditions, earlier return to normal feeding and GI function is a positive result for these patients.”

POI is thought to be caused in part by the interaction of opioid pain relievers with mu-opioid receptors in the GI tract inhibiting bowel function and motility. It is associated with abdominal distension and bloating, persistent abdominal pain, nausea and vomiting, variable reduction of bowel sounds, delayed passage of or an inability to pass flatus (gas) or stool, and an inability to tolerate oral intake or progress to a solid diet.

Opioid analgesics, such as morphine, are widely used for the treatment of postoperative pain. Entereg works by binding to mu-opioid receptors in the gut, thereby selectively inhibiting the negative effects of opioid medications on GI function and motility.

Entereg is for hospital use only. The recommended adult dose of Entereg is a single 12 mg capsule administered orally 30 minutes to five hours prior to surgery followed by a 12 mg capsule twice daily beginning the day after surgery for a maximum of seven days or until discharge, not to exceed 15 doses (see Important Safety Information below).

The FDA lifted the clinical hold on the Entereg capsule investigational new drug application (IND) for POI. The companies plan to commence a study in patients undergoing radical cystectomy, another population in which POI is a significant burden, as part of a postmarketing commitment.

E.A.S.E.™ Program for Hospital Registration

The FDA has approved Entereg with a Risk Evaluation and Mitigation Strategy (REMS). As part of the REMS, Adolor has developed the Entereg Access Support and Education (E.A.S.E.) program. Under the E.A.S.E. program, Entereg will be made available only to hospitals that complete a registration process. The E.A.S.E. program is designed to maintain the benefits associated with short-term use in the bowel resection population and prevent long-term, outpatient use.

Important Safety Information About Entereg

The Entereg full prescribing information has a boxed warning that states Entereg is available only for short-term (15 doses) use in hospitalized patients. Only hospitals that have registered in and met all requirements of the Entereg Access Support & Education (E.A.S.E.) program may use Entereg.

Entereg is contraindicated in patients who have taken therapeutic doses of opioids for more than 7 consecutive days immediately prior to taking Entereg.

There were more reports of myocardial infarctions in patients treated with alvimopan 0.5 mg twice daily compared with placebo-treated patients in a 12-month study of patients being treated with opioids for chronic pain. This imbalance has not been observed in studies in patients undergoing bowel resection surgery who have received alvimopan 12 mg twice daily for up to 7 days. A causal relationship with alvimopan has not been established.

Overall, the incidence of adverse events in short-term surgical clinical trials was similar between patients receiving either Entereg or placebo. In clinical studies, the most common adverse reactions in patients receiving Entereg following bowel resection were anemia, dyspepsia, hypokalemia, back pain, and urinary retention.

For more information about Entereg, including full prescribing information, visit www.entereg.com.

ABOUT GLAXOSMITHKLINE

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit GlaxoSmithKline on the World Wide Web at www.gsk.com.

DIAMANT ART CORPORATION (OTCBB: DIAAF)
"Up 25.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/DIAAF.php

Diamant Art Corporation Inc., through its wholly owned subsidiary Diamant Film Inc. (www.diamantfilm.com) and Bio-Plastics Film Inc., is the world's first plasticizer-free and the first food wrap film that is environmentally friendly and recyclable. Diamant's Bio-Products contain Totally Degradable Plastic Additive. Unlike other plastic, once the biodegrading process is complete, all that will remain is carbon dioxide, water, non toxic mineral salts and biomass, all of which will become part of the normal bio-cycle. Diamant™ Film has recently received the ECO logo certified by the Environmental Choice™ Program. The Environmental Choice™ Program is North America's leading benchmark of environmentally responsible products and services and the sole supplier of the Nor-X "Renutra" additive in North America.

DIAAF News:

May 21 - Diamant Art Corporation Announces the Review of House Bills by Senate and House Lawmakers in Rhode Island Aimed at Non-Biodegradable Plastic Bags and Bottles

Diamant Art Corporation (OTCBB: DIAAF) through its wholly owned subsidiary Diamant Film Inc. (www.diamantfilm.com) and Bio-Plastics Film Inc. announced that Senate and House lawmakers have recently introduced a total of four bills this year aimed at reducing the consumption of non-biodegradable plastic bags and bottles in Rhode Island, and one designed to reduce litter and increase our recycling rate of non-biodegradable beverage containers.

According to the Environmental Council of Rhode Island (www.environmentcouncilri.org/news.html), the ECRI Legislative Agenda for 2008 includes bills written to enforce a reduction of waste created by plastic bags. Plastic bags, while requiring petroleum to produce, consume energy to manufacture, create litter, choke marine life and add to landfill waste. On this basis, ECRI supports legislation that would ban plastic bags (H7444), or discourage their use by mandating a refund for customers who bring reusable bags (H7159) (S2565), or by taxing them (H7630). ECRI supports beverage container deposit recycling to reduce litter and increase our recycling rate (S2771).

"We have more than enough garbage at the Central Landfill," said Rep. Amy Rice, D-Portsmouth. "It seems like unnecessary waste."

Rice, the sponsor of a House bill that would require stores to give a 3-cent rebate to customers who bring their own bags, said last week she was going to change the bill to include a 5-cent tax on plastic bags starting in mid-2009 and a phase out of their use by July 1, 2010.

The Rhode Island Resource Recovery Corporation, the independent state agency that runs the Central Landfill in Johnston, estimates that Rhode Islanders consume 192 million plastic grocery bags a year. The number is closer to 300 million when bags from pharmacies, large retailers and produce and deli bags are factored in.

ENVIRONMENTAL CONTROL CORPORATION (OTCBB: EVCC)
"Up 50.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/EVCC.php

Environmental Control Corporation is a developer of Emission Control Devices for small Spark Ignition (SI) combustion engines. Typical devices within this spectrum include: walk behind rotary mowers, rear engine riding mowers, front engine lawn tractors, riding garden tractors, snow throwers, commercial turf mowers, chainsaws, hand held blowers, backpack blowers, trimmers/brush cutters, mopeds, scooters, snowmobiles, all-terrain vehicles and personal water crafts. Small SI engines produce approximately one tenth of U.S. mobile source hydrocarbon (HC) emissions and are the largest single contributor to non-road HC inventories.

EVCC News:

May 20 - Environmental Control Corporation Acquires Second Canadian Patent

Environmental Control Corporation (OTCBB: EVCC) ("EVCC") announced the approval of its second Canadian Patent. The Reverse Flow Catalytic Muffler, Canadian Patent # 2,448,648, now accompanies Canadian Patent # 2,448,742 — The Combined Catalytic Muffler. Other intellectual property currently held by EVCC includes two U.S. Patents: The Reverse Flow Catalytic Muffler (U.S. Patent # 7,018,590) and The Combined Catalytic Muffler (U.S. Patent # 6,622,482); and one pending patent in Europe: the Reverse Flow Catalytic Muffler (Patent Application # 02742591.7). It is anticipated that the European patent application will be approved and registered in the near future.

EVCC, in partnership with Richards Engine Development (R.E.D.), continues to work on the development of its two-stroke 185 cc catalytic muffler design. A further press release will be disseminated announcing the completion of this one-piece catalytic muffler design, as well as a press release announcing the final test date at Intertek Carnot Emission Services (Intertek CES) in San Antonio, TX.

TRANSAX INTERNATIONAL LIMITED (OTCBB: TNSX)
"Up 100.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/TNSX.php

Transax International Limited, together with its subsidiary, Medlink Connectividade em Saude Ltda, provides health information management products and solutions to manage coding, compliance, reimbursement, abstracting, and record management's processes for healthcare providers and health insurance companies. Its compliance management, and coding and reimbursement management solutions help to conduct automated prospective and retrospective reviews of in-patient and out-patient claims data. The company's abstracting solutions enable healthcare facilities to collect and report patient demographic and clinical information. Its record management solutions automate the record tracking and location functions, monitor record completeness, and facilitate the release of information process within health information management departments. Transax International offers MedLink Solution, a software that enables the real time automation of routine patient eligibility, verification, authorizations, claims processing, and payment functions. It serves healthcare providers, such as physicians, clinics, hospitals, laboratories, diagnosis centers, and emergency centers; and health insurance and group medicine companies with operations in the United States, Brazil, Australia, and Mauritius. The company has strategic alliances with Centro Brasilerio De Informatica Medica S/A; Mosaic Software, Inc.; and Hypercom Corporation to support its MedLink Solution's system architecture and design. Transax International is based in Miami, Florida.

TNSX News:

May 21 - Transax International Reports Record Revenues and Profitable First Quarter 2008 Results

Transax International Limited (OTCBB: TNSX) (Transax), a network solutions company for healthcare providers and health insurance companies, reported record financial results for the first quarter ended March 31, 2008.

For the quarter ending March 31, 2007, Transax generated net revenues of $1,480,964 compared to $1,186,226 in net revenues during first quarter of 2007, a 25% increase. The increase in revenue was reflected in rollout of previously announced contracts and increasing percentage of POS transactions. The increase in revenues also reflects a currency gain from the weakening US dollar. Transaction volume for the quarter was 2.1 million.

Income from operations in the first quarter of 2008 was $125,379 compared with $113,900 income during the same period in 2007. Net income for the first quarter of 2008 was $739,863, or $0.02 per share, compared with net income in the first quarter of 2007 of $402,005, or $0.01 a share. The increase in net income is principally due to an improvement in derivative liability expenses.

For the quarter ending March 31, 2008, the Company incurred $1,355,585 in operating expenses compared to $1,072,326 during the same period in 2007. The majority of the increase in expenses was attributed to increases in compensation and benefits with respect to the Company's Brazil operations and increases in professional fees throughout the quarter due to the sale of a minority interest. During the quarter the Company signed additional contracts in Brazil however no revenues were recorded.

During the quarter ending March 31, 2008 the Company sold a 45% minority interest in its Brazil operations for $3.2 million and a potential performance bonus payable in 2009. A deposit of $200,000 was paid in December 2007 and $600,000 paid on closing of the transaction. The balance of $2.4 million is to be paid in monthly installments through to April 2009.

Stephen Walters, President & CEO of Transax stated, "I am very pleased to announce a profitable quarter for the Company's operations. The Company's sale of a 45% minority interest will materially help in reducing the Company's debt while providing capital to review other potential business for Transax. In addition, the Company has been in negotiations to sell the U.S. rights to its product with due diligence being undertaken by a potential buyer during the quarter. There is no guarantee a transaction for the U.S. rights will be consummated, however we will continue to inform the investment community on any updates available."

GLOBAL ENTERTAINMENT ACQUISITION CORPORATION (OTC: PSRZ)
"Up 29.58% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PSRZ.php

Global Entertainment Acquisition Corporation, currently doing business as Pop Starz Incorporated, is an emerging film production company headed by Maurice Smith, a veteran filmmaker who has produced many successful and memorable films such as "Screwballs," "Totally Blonde," "Alien Predator," "Recruits 1 and 2" and many other films over his distinguished 30-year career. His films have been distributed in virtually every country in the world and has distribution on several films currently with some of the largest film distributors in the world. The company will focus on producing small budget films in the Comedy and Sci Fi genres while searching for and developing emerging talent including writers, directors and actors to work on their films. In an era of expanded outlets of distribution, content is in higher demand than ever. it is Global's mission to become a leading content provider of entertaining, high quality films to feed the global demand.

PSRZ News:

May 21 - Global Entertainment Announces First Production; Superhero Sci-Fi Thriller 'Spiderella'

Maurice Smith's First Feature as Global's CEO to Feed Public's Insatiable Appetite for Superhero Flix

Global Entertainment Acquisition Corporation (OTC: PSRZ) announced that it has secured the filming rights to the screenplay "Spiderella," a Sci-Fi thriller it hopes will launch the newest Super-Heroine, Spiderella. The new feature film and music production company, located in Beverly Hills, CA, selected the screenplay as the vehicle in which to launch its company, in order to feed what the company believes is the insatiable appetite of audiences for Super Hero flix. "Just look at this past two weeks with the powerhouse 'Ironman,' which grossed $200,000,000.00 worldwide in its first week in theatres, and the ads permeating our media for 'Hulk,'" says newly appointed CEO Maurice Smith. "It is clear what the public wants and we will give it to them with this incredibly entertaining feature film." The company has already begun pre-production on the film, and will begin to cast the picture soon. It is expected to begin shooting the thriller mid-summer.

Additionally, the company announced the launch of its Web site, www.globalentertainmentcorp.com, and hired multi-platinum music maven, Del, to head up its music division, which the company expects to become a major force not only as a vendor for film production companies worldwide, but as a tremendous resource for the company's in-house productions.

"Needless to say, Del has the pedigree to deliver outstanding, cutting edge music and will enhance our film's entertainment production values immensely," says CEO Smith.

MM2 GROUP INCORPORATED (OTCBB: MMGP)
"Up 11.11% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MMGP.php

MM2 Group, Inc., through its subsidiary, Genotec Nutritionals, Inc., engages in the formulation, marketing, and distribution of nutritional supplements and vitamins in the United States. It sells various products, including fish oil, grape powder, resveratrol, lutein, and psyllium powder, as well as various custom formulations, such as formulations for diet, cardiac support, eye support, immunity support, and aging support. The company also sells custom formulations for pet care, including a shedding formula, a coat formula, dog and cat joint formulas, and pet multi-vitamins for dogs and cats. MM2 Group is based in Livingston, New Jersey.

MMGP News:

May 21 - MM2 Group Reports Record Net Income of $2,019,862 for Quarter Ending March 31, 2008

MM2 Group, Inc. (OTCBB: MMGP) reported on May 20, 2008, in a Form 10-QSB filing with the Securities and Exchange Commission, net income of $2,019,862 for the quarter ending March 31, 2008, which is the third quarter of fiscal 2008 for the Company. In the same time period last year, the Company reported income of $254,223.

Total sales for the three months ended March 31, 2008 and 2007 were $685,663 and $247,954, respectively. The increase in sales in 2008 was derived from the sales of nutritional supplements by Genotec Nutritionals, Inc., the Company's wholly-owned subsidiary.

Total other (income) expense for the three months ended March 31, 2008 was an income of $2,169,040. This total was comprised of a gain on revaluation of derivatives of $2,711,630. This amount was offset by ammortization of the discount on debt conversion of $223,344, liquidated damages of $108,275, interest expense of $47,387 and beneficial interest expense of $165,074. Loss from operations for the three months ended March 31, 2008 equaled $149,178 versus a loss of $492,597 in the same period last year.

This financial performance is a record in the history of the MM2 Group.

Mark Meller, CEO of MM2 Group, commented, "We are proud to report these results for the third quarter of 2008. The management team at Genotec Nutritionals, our wholly-owned subsidiary, is doing an excellent job of delivering great results. We look forward to continuing to deliver superior results throughout the rest of the year. Shareholders should read the complete details of our third quarter results in the Company's recently filed Form 10-QSB."

VIASPACE INCORPORATED (OTCBB: VSPC)
"Up 21.62% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VSPC.php

VIASPACE, Inc. commercializes space and defense technologies from NASA and the department of defense into hardware and software products in the United States. The company provides disposable fuel cartridges and intellectual property protection for manufacturers of direct methanol and other liquid hydrocarbon fuel cells; and develops products and services based on inference and sensor data fusion technology. It also develops mass spectrometry technology that improves the application of mass spectrometry for industrial process control and environmental monitoring, and produces detection systems for homeland security, as well as holds patents and various patent applications in the areas of interactive radio technology. The company's direct methanol fuel cell-based products are developed for laptop computers, cell phones, music players, and other applications. It offers its services in the areas of energy/fuel cells, microelectronics, sensors and software for defense, homeland security and public safety, and information and computational technology. VIASPACE was founded in 1998 and is based in Pasadena, California.

VSPC News:

May 20 - VIASPACE Wins Global Distributorship for HYB Premium Lithium Ion Batteries

VIASPACE Inc. (OTCBB: VSPC) announced that it has signed an agreement to globally distribute the rechargeable lithium ion batteries produced by HYB Battery Co. Ltd, a technology leader in China. HYB, founded in 1999, produces high-quality, yet low-cost batteries. HYB batteries are used in a wide range of portable electronic applications, a $6 Billion market sector, including notebook computers, digital video and still cameras, GPS devices, and mobile phones. In addition, HYB also produces high discharge rate batteries for power tools, uninterruptible power supplies and light electric vehicles. HYB high quality has been audited and certified by 12 major customers. Its current customer list includes industry leaders such as Samsung, Tyco, Garmin, Philips, VARTA, Foxconn, and CelExpert.

HYB Battery Co. Ltd.'s 500,000 m2 manufacturing facility is located in Shenzhen, China. With 1600 employees and modern automated equipment, HYB's current capacity is 300,000 pieces per day. Production capacity is scheduled to double in the next 12 months. HYB has extensive quality and safety control procedures. They are ISO 9001 and 14001 certified, and their products are approved by Underwriters Laboratories (UL), CE marked and RoHS compliant. HYB produces cylindrical cells in the standard 18650, 14430 and other sizes. They have 20 different sizes of prismatic cells, and high-capacity cells with energy storage capacities ranging from 8-80 amp hours.

VIASPACE CEO Carl Kukkonen stated, "HYB has the precision batteries needed for demanding applications that require highest uniformity and quality, such as such as notebook computers and cell phones HYB already has batteries in commercial digital video and still cameras, cordless phones, and portable GPS systems. We will represent HYB in their existing market sectors, and develop new business in high-power applications such as power tools, electric bicycles and scooters, where we see market projections of a 400% increase in sales in the next two years. The VIASPACE Energy business unit focuses on alternative energy and portable power solutions. HYB adds great new rechargeable battery product line that complements our current battery and fuel cell products. HYB manufactures high quality batteries with an excellent safety record, and they sell them at a substantially lower cost than their Japanese and Korean competitors that currently dominate this $6 Billion marketplace."

VOYANT INTERNATIONAL CORPORATION (OTCBB: VOYT)
"Up 26.25% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VOYT.php

Voyant International Corporation, a media and technology holding company, focuses on identifying and developing various media-based technologies, media assets, and strategic partnerships to deliver commercial and consumer solutions. The company, through its subsidiary, Rocketstream Holding Corporation, develops a protocol technology to deliver rich-media content over the Internet. Its combined suite of technologies comprises integrated components based on its proprietary packet protocol, data encryption technologies, and acceleration transports. RocketStream provides its technologies for the delivery of video, audio, and groupware chat, as well as bi-directional voice over IP facilities; and a solution for file transfer and media delivery over IP network. The company's other subsidiary, Centerpoint Broadband Technologies, operates as an optical networking and wireless communications company. It builds an optical networking platform and a broadband wireless platform around high speed communication technologies for military applications. Voyant International has a joint venture to develop the Sports Immortals Cyber Museum internet portal, an immersive and interactive online showcase that celebrates the memories and achievements of the athletes in sports history. The company was founded in 1994 as Zeros & Ones, Inc. and later changed its name to Voyant International Corp. in April, 2007. Voyant International is headquartered in Palo Alto, California.

VOYT News:

May 21 - Voyant Receives $2 Million Order for White Space Radios

New Product Line to Serve Large, Innovative Wireless Data Applications

Voyant International Corporation (OTCBB: VOYT), a diversified digital media and technology holding company, announced that it has entered the high-growth wireless communications market and has received a $2 million contract for the development and production of the first 3,000 White Space Radios (WSRs). This WSR program is part of Voyant's ongoing strategy to combine existing and new technologies with the company's substantial portfolio of intellectual property and domain knowledge in order to address large, emerging applications in the wireless sector.

The Voyant WSR is a novel, advanced broadband radio that will utilize the so-called spectral white space soon being made available by the FCC. The white space spectrum represents over 200 MHz of valuable bandwidth in the VHF/UHF band. These frequencies support high-capacity, long-range and reliable wireless communications, making them particularly useful for innovative new services, including so-called WiFi 2.0 applications.

The flexible design of Voyant's WSR will allow it to be easily configured to support a broad range of other customers and applications. The software-defined WSR can be reprogrammed over-the-air, allowing it to be remotely upgraded or reconfigured, and will be capable of operation from 174 MHz to 1 GHz. Consequently, it can be used by auction winners of the lower and upper 700 MHz bands, as well as in the 900 MHz unlicensed bands. In addition, Voyant may use the WSR in its own aviation broadband service, which intends to bring true broadband service to commercial airline passengers.

Under the terms of this initial contract, Voyant will design and deliver 3,000 WSRs over multiple years. Voyant's launch customer will use these radios for a variety of applications, including "green," energy-efficient, utility and power management.

"The white space spectrum represents a new frontier for innovation in wireless communications, and this program establishes Voyant as a pioneer and leader in the WSR field," explained Ed Gerhardt, Voyant's general manager of wireless systems. "Our technological skill set, intellectual property and experience in wireless systems make Voyant particularly well-suited to undertake this challenging and exciting project and open the door to a host of exciting new applications and markets."